Victrex plc Annual Report and Accounts 2011 Notes to the Financial Statements continued 2.
Segment reporting The Groups business is strategically organised as two business units: Victrex Polymer Solutions, which focuses on our transport, industrial and electronics markets and Invibio Biomaterial Solutions, which focuses on providing specialist solutions for medical device manufacturers.
Victrex Invibio Victrex Invibio Polymer Biomaterial Polymer Biomaterial Solutions Solutions Group Solutions Solutions Group 2011 2011 2011 2010 2010 2010 m m m m m m Revenue from external sales 166.1 49.7 215.8 145.3 44.2 189.5 Segment operating profit 66.8 30.3 97.1 48.3 28.1 76.4 Unallocated central costs 3.3 1.5 Operating profit 93.8 74.9 Net financing income 0.4 Profit before tax 94.2 74.9 Income tax expense 23.0 20.9 Profit for the year attributable to owners of the parent 71.2 54.0 Other information Depreciation 8.5 0.3 8.8 8.3 0.2 8.5 Amortisation 0.2 0.2 Entity wide disclosures Information about products and services The Group derives its revenue from the sale of high performance thermoplastic polymers.
Information about geographical areas The Groups country of domicile is the United Kingdom.
Revenues are attributed to customers based on the customers location.
Revenue from external sales 2011 2010 m m United Kingdom 5.3 3.8 Europe, Middle East and Africa EMEA 97.0 85.6 Americas 73.6 68.0 AsiaPacific 39.9 32.1 215.8 189.5 Information about major customers Revenue derived from one of the Groups customers amounted to 24.3m 2010: 22.7m of the Groups total revenue from external customers and is included in both segmental revenues.
